Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Cut to $36.00 by Analysts at Royal Bank of Canada
Intra-Cellular Therapies (NASDAQ:ITCI) had its price objective decreased by Royal Bank of Canada from $43.00 to $36.00 in a research note issued to investors on … Read more